insights_auto
Kwa nini DRREDDY imeongezeka kwa 2.71%?
Fahamu zaidichevron_right
DRREDDY:NSE
Dr Reddy's Laboratories Ltd
₹ 1,229.40
arrow_upward
+2.71%(+32.40) Siku 1
12 Okt, 15:30:00 GMT +5:30 · INR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya DRREDDY...
Fungua
₹ 1,197.00
Juu
₹ 1,235.00
Chini
₹ 1,196.90
Mtaji wa soko
1.02T
Wastani wa kiasi cha mauzo
1.79M
Kiasi cha mauzo ya hisa
1.76M
Gawio
0.65%
Mgawo wa faida wa kila robo mwaka
₹ 2.00
Tarehe ya kutojumuisha gawio
10 Jul 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
31.79
Juu kwa wiki 52
₹ 1,414.90
Chini kwa wiki 52
₹ 1,101.00
EPS
₹ 38.67
Hisa za wawekezaji
166.06M
Idadi ya wafanyakazi
elfu 28
Fungua
₹ 1,197.00
Juu
₹ 1,235.00
Chini
₹ 1,196.90
Mtaji wa soko
1.02T
Wastani wa kiasi cha mauzo
1.79M
Kiasi cha mauzo ya hisa
1.76M
Gawio
0.65%
Mgawo wa faida wa kila robo mwaka
₹ 2.00
Tarehe ya kutojumuisha gawio
10 Jul 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
31.79
Juu kwa wiki 52
₹ 1,414.90
Chini kwa wiki 52
₹ 1,101.00
EPS
₹ 38.67
Hisa za wawekezaji
166.06M
Idadi ya wafanyakazi
elfu 28
Hisa zinazohusiana
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
marketscreener.com
·
dakika 11 zilizopita
US stock futures steady as oil jumps to two-week high ahead of key earnings
TradingView
·
dakika 42 zilizopita
The S&P 500 celebrates latest bull market anniversary
Barron's
·
dakika 17 zilizopita
S&P 500 Futures Up in Premarket Trading; Westlake, Core & Main Lead
Stocktwits
·
saa 4 zilizopita
Why Are Nasdaq Futures Rising Premarket? MU, IREN, SLS, NIO, ASTS, WFF Stocks In Focus
Wasifu
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Kuhusu Dr Reddy's Laboratories Ltd
Afisa Mkuu Mtendaji (CEO)Erez Israeli
Wafanyakazielfu 27.5
Lilianzishwa1984
Makao makuuHyderabad, Andhra Pradesh, India
Sekta-
Tovutidrreddys.com